| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.084 | 0.2 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |